Lawyer Bio : Thomas A. Cawley, Jr. Ph.D.
Printable Bio (PDF)
Thomas A. Cawley, Jr. Ph.D.
Tysons Corner
Dr. Cawley’s practice focuses on biotechnology patent prosecution, opinion work, and client counseling, including the design and implementation of global intellectual property strategies.
Among the technologies with which Dr. Cawley has experience are gene therapy, transgenic animals, genomics, recombinant herpes simplex viruses, recombinant production of procaryotic and eucaryotic gene products, small molecule technologies, antibody technologies, immunocontraception, novel adjuvant therapies, screening methods for the identification of novel drug candidates, cancer therapy, and methods and compositions for the treatment of a variety of neurological conditions.
Dr. Cawley received his doctorate in Physiology and Biophysics from Drexel University College of Medicine (Philadelphia, PA). His graduate research involved elucidating the effects of chronic treatment with various pharmacological agents used in the treatment of schizophrenia and other psychotic like behaviors, specifically addressing effects on cell-surface receptors in the central nervous system as well as the periphery. He has authored several articles in scientific peer-review publications.
Contact
- (703) 394-2210
- (703) 918-2240
Professional Activities
Bar Associations: District of Columbia Bar Association; Illinois State Bar Association; American Intellectual Property Law Association; American Society of Pharmacology & Experimental Therapeutics.
Admitted to bar: 1996, Illinois; 1998, District of Columbia; 2004, Virginia.
Admitted to practice before the United States Patent and Trademark Office; Supreme Court of Virginia, Court of Appeals of the District of Columbia; Supreme Court of the State of Illinois, U.S. District Court of the Northern District of Illinois.
Education
B.S., Biology; B.S., Political Science, 1986, University of Scranton.
Ph.D., Physiology & Biophysics, 1993, Drexel University College of Medicine.
J.D., 1996, University of New Hampshire School of Law (formerly Franklin Pierce Law Center).
Ph.D., Physiology & Biophysics, 1993, Drexel University College of Medicine.
J.D., 1996, University of New Hampshire School of Law (formerly Franklin Pierce Law Center).
Prior Legal Experience
Partner, Pillsbury Winthrop Shaw Pittman LLP, Mclean, Virginia, 2005-2009; Senior Patent Attorney, Pillsbury Winthrop Shaw Pittman LLP, McLean, Virginia, 2002-2004; Associate Patent Attorney, Marshall, Gerstein & Borun LLP, Chicago, Illinois, 1996-2002.
Publications
Cawley, T.A. Jr., Shickey, T.J., Ruggieri, M.R., and Luthin, G.R., “Effect of chronic neuroleptic treatment on central and peripheral muscarinic acetylcholine receptors,” Journal of Pharmacology and Experimental Therapeutics, 267(1): 134-139, October 1993.
Cawley, T.A. Jr. and Shickley, T.J. “The Potential neurotoxin 2-OH-dopamine is an inhibitor of arylsulfatase,” Annals of the New York Academy of Sciences 648: 256-259, 1992.
Presentations
“Muscarinic Acetylcholine Receptors in the Urinary Bladder,, Soc. Neurosci. Abstr., 19(2): 1767, 23rd Annual National Meeting for the Society of Neuroscience, Washington, DC, 1993.
“Effect of Chronic Neuroleptic Treatment on Central Muscarinic Receptors,” Soc. Neurosci. Abstr., 17(1): 609, 21st Annual National Meeting for the Society of Neuroscience, New Orleans, LA, 1991.
“Enzyme Kinetics of Dopamine Inhibition of Arylsulfatase-C,” Soc. Neurosci. Abstr., 15(1): 936, 19th Annual National Meeting for the Society of Neuroscience, Phoenix, AZ, 1989.
“Hydroxyl Adducts of Dopamine are Potent Inhibitors of Arylsulfatase-C,” Soc. Neurosci. Abstr. 14(2): 1075, 18th Annual National Meeting for the Society of Neuroscience, Toronto, Ontario, Canada, 1988.
Areas of Proficiency
- Intellectual Property